ClinicalTrials.gg
CompletedNCT05290233Updated Sep 26, 2024

Time Restricted Eating Plus Exercise for Weight Management

An interventional study of TRE + Exercise in Intermittent Fasting, Pre Diabetes and Cognitive Decline, sponsored by University of Illinois at Chicago. Completed at 1 site in United States. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-26.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

Time restricted eating (TRE) is currently the most popular form of intermittent fasting which involves confining the eating window to 8-10 hours (h) and fasting for the remaining hours of the day. TRE is unique in that during the eating window, individuals are not required to count calories or monitor food intake in any way, resulting in high adherence. Accumulating evidence suggests that TRE produces a natural energy deficit of \~350-500 kcal/d. Physical activity in combination with a healthy diet pattern is recommended for older adults. While aerobic type exercise is the most commonly recommended, retention of lean mass via resistance training, especially in older adults, may be more effective at improving mobility, neurological and psychological function, executive and cognitive functioning, and processing speed. TRE combined with physical activity has not been examined in older adults or in people with overweight or obesity. This study holds the potential to 1) decrease body weight 2) improve lean mass 3) improve insulin sensitivity, and 4) improve attention, executive functioning, and processing speed in older adults. The aims of this study will examine the effect of TRE combined with either resistance training or aerobic training on body weight, body composition, metabolic disease risk, and cognition in adults over age 50. It is hypothesized that the TRE combined with resistance training group will see the most significant improvements in body composition, insulin sensitivity and cognition due to lean mass accretion.

Read the detailed description

Time restricted eating (TRE) is currently the most popular form of intermittent fasting which involves confining the eating window to 8-10 hours (h) and fasting for the remaining hours of the day. TRE is unique in that during the eating window, individuals are not required to count calories or monitor food intake in any way, resulting in high adherence. Accumulating evidence suggests that TRE produces a natural energy deficit of \~350-500 kcal/d. Physical activity in combination with a healthy diet pattern is recommended for older adults. While aerobic type exercise is the most commonly recommended, retention of lean mass via resistance training, especially in older adults, may be more effective at improving mobility, neurological and psychological function, executive and cognitive functioning, and processing speed. T TRE combined with physical activity has not been examined in older adults or in people with overweight or obesity. This study holds the potential to 1) decrease body weight 2) improve lean mass 3) improve insulin sensitivity, and 4) improve attention, executive functioning, and processing speed in older adults. This study will examine the effect of TRE combined with either resistance training or aerobic training on body weight, body composition, metabolic disease risk, and cognition in adults over age 50. It is hypothesized that the TRE combined with resistance training group will see the most significant improvements in body composition, insulin sensitivity and cognition due to lean mass accretion.

02

Conditions studied

  • Intermittent Fasting
  • Pre Diabetes
  • Cognitive Decline
03

In context

Intermittent Fasting

155 studies on the registry are indexed under Intermittent Fasting; 68 are open to participants now.

This study's enrollment of 36 is below the median of 58 across 151 interventional studies indexed under Intermittent Fasting.

Browse Intermittent Fasting studies →

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 523 studies on the registry; 132 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with obesity (BMI between 30-50kg/m2)
  • pre-diabetes (fasting glucose: 100-125 mg/dl or HBA1c 5.7%-6.4% or OGTT ≥ 200 mg/dl)
  • sedentary or lightly active (\<7,500 steps/day)
  • between the ages of 50-80 years

Exclusion criteria

Exclusion Criteria:

  • diagnosed with T1DM or T2DM (fasting glucose: >126 mg/dl, 2-h glucose OGTT ≥ 200 mg/dl,
  • HbA1c: >6.5%)
  • Individuals with a history of eating disorders
  • shift workers
  • Individuals taking drugs to control body weight and glucose (including metformin)
  • individuals who are not weight stable (weight gain or loss > 4 kg) 3 months prior to the intervention
  • mobility disorders or individuals unable to exercise for 40-60 minutes 3-4 days/week
  • Individuals diagnosed with comorbidities impacting cognition, including major/mild neurocognitive disorder, cerebrovascular disease (e.g., stroke, aneurysm, arteriovenous malformation), traumatic brain injury, epilepsy, or major psychiatric disorder (e.g., schizophrenia, bipolar disorder, substance use disorder)
  • Individuals who are unable to adequately report dietary intake or physical activity
  • Smokers
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    TRE+RT

    Participants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised resistance training per week.

    Behavioral: TRE + Exercise

  • Active comparator
    TRE+AT

    Participants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised aerobic training per week.

    Behavioral: TRE + Exercise

Interventions

  • BehavioralTRE + Exercise

    We will compare the effects of TRE combined with resistance exercise versus TRE combined with aerobic training. Other Names: resistance training endurance exercise

06

What researchers measure

Primary outcomes

  1. Lean mass

    fat free mass will be measured via DXA

    Time frame: change from week 1 to week 12

Secondary outcomes

  1. body weight

    Body weight assessed to the nearest 0.25 kg every week without shoes and in light clothing using a balance beam scale (HealthOMeter, Boca Raton, FL).

    Time frame: change kg of body weight from week 1 to week 12

  2. fat mass

    fat mass will be measured via DXA

    Time frame: change kg of body weight from week 1 to week 12

  3. Visceral fat mass

    visceral fat mass will be measured via DXA

    Time frame: change kg of body weight from week 1 to week 12

  4. Insulin

    measured by enzymatic kit (uIU/ml)\^4

    Time frame: change from week 1 to week 12

  5. glucose

    measured by enzymatic kit (mg/dl)

    Time frame: change from week 1 to week 12

  6. HbA1c

    measured by enzymatic kit (mmol/mol)

    Time frame: change from week 1 to week 12

  7. Attention

    National Institutes of Health Toolbox Cognition Battery

    Time frame: Change from week 1 to week 12

  8. executive function

    National Institutes of Health Toolbox Cognition Battery

    Time frame: Change from week 1 to week 12

  9. processing speed

    National Institutes of Health Toolbox Cognition Battery

    Time frame: Change from week 1 to week 12

07

Study locations

1 site
  • University of Illinois at Chicago
    Chicago, Illinois 60612, United States
08

References and documents

Publications

  • Sanchez Perez J, Czyzewski O, Hamm A, Fought-Boudaia A, Cares K, Motl RW, Gabel K. Feasibility and acceptability of 8-h time-restricted eating combined with aerobic or resistance training in older adults with prediabetes and obesity. Ann Behav Med. 2026 Jan 7;60(1):kaag060. doi: 10.1093/abm/kaag060. PubMed 42847405 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2023 to primary completion in Jul 2024, 9 months.

Of 127 non-industry interventional studies with no phase under Intermittent Fasting, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 38. This study's 9 months is below that.

Counting every sponsor, half of 128 studies reached it within 20 months; a quarter within 11 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2022
First posted
Mar 22, 2022
StartActual
Sep 21, 2023
Primary completionActual
Jul 18, 2024
CompletionActual
Jul 18, 2024
Last update
Sep 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05290233
Responsible party
Kelsey Nicole Dipman Gabel (Clinical Assistant Professor and Postdoctoral Researcher, University of Illinois at Chicago) — Principal investigator
First posted
Mar 22, 2022
Start date
Sep 21, 2023
Primary completion
Jul 18, 2024
Completion
Jul 18, 2024
Last update
Sep 26, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion